Dexcel Pharma Technologies Ltd. Insider Trading Activity

Average Profitability
38.64%
Insider Buys Quantity
3
Insider Buys Sum
$40.15M
Insider Sells Quantity
2
Insider Sells Sum
$2.09M

Insider Activity of Dexcel Pharma Technologies Ltd.

Biography of Dexcel Pharma Technologies Ltd.

No biography is available at this moment.

2022-11-10PurchaseRoivant Sciences Ltd.
ROIV
director
8M
1.0825%
$5.00$40M+74.52%
2022-04-25PurchaseRoivant Sciences Ltd.
ROIV
10 percent owner
8,600
0.0012%
$3.91$33,635+19.01%
2022-04-22PurchaseRoivant Sciences Ltd.
ROIV
10 percent owner
31,685
0.0045%
$3.83$121,319+22.38%
2021-06-03SaleProtalix BioTherapeutics, Inc.
PLX
10 percent owner
857,506
1.9156%
$2.25$1.93M-48.2%
2021-06-02SaleProtalix BioTherapeutics, Inc.
PLX
10 percent owner
61,211
0.1389%
$2.56$156,553-53.63%
Total: 5
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.